Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-24 @ 9:55 PM
NCT ID:
NCT03514732
Brief Summary:
Primary Objective:
To estimate the range of improvement of NOVANUIT® triple action on sleep quality global score.
Secondary Objectives:
* To estimate the range of improvement of NOVANUIT® triple action on following parameters: time for getting asleep, sleep time, number of nocturnal awakening, number of nightmares, sleep quality (score from 0 to 10), and mean tiredness during the day (score from 0 to 10).
* To estimate persistency of NOVANUIT® triple action effects after end of study product consumption.
* To assess dependency to NOVANUIT® triple action after study product cessation.
* To assess tolerance of NOVANUIT® triple action during the study.
Detailed Description:
Study participation duration for each participant will be 4 weeks including a 2-week treatment period.
Study:
NCT03514732
Study Brief:
Protocol Section:
NCT03514732